Entod Pharmaceuticals Limited - Due diligence report

A 360° intelligence report on Entod Pharm: trust score, financial health, credit view, compliance, directors, growth and distress signals - …

1981-10-31 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
EP Entod Pharmaceuticals Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Entod Pharm — 360° Intelligence Report

Generated from MCA filings & public records
77/100
Trust Score
Low Risk

Entod Pharm is assessed as Low Risk with a Trust Score of 77/100. Entod Pharm is an active public limited indian non-government company incorporated in 1981, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 20 Jul 2026 from the latest processed filings. Entod Pharmaceuticals Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
38/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 2 open (25.55 cr) · 23 satisfied (22.88 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others6 48.0 cr
Hdfc Bank Limited2 48.0 cr
The Saraswat Co-Operative Bank Limited4 48.0 cr
The Saraswat Co-Operative Bank Ltd3 48.0 cr
The Saraswat Co-Oprative Bank Limited5 48.0 cr
The Saraswat Cooperative Bank Ltd.2 48.0 cr
Compliance Score: 38/100 Caution Indicated
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: EPFO.
  • Litigation present in 2 court forum(s).
  • 1 auditor resignation(s) filed - latest: S S Puranik & Associates on 2019-08-31.
  • Delayed payments to MSME suppliers disclosed (59 disclosure(s)).
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
DHARMESH PRAVIN KHARWAR 01234567 Director 01/04/2018 6 yrs Approved
VIVEK MANOHAR PADGAONKAR 01234567 Director 01/04/2018 6 yrs Approved
KISHORE GURUDAS MASURKAR 01234567 Director 01/04/2018 6 yrs Approved
VIVEK RAJENDRA SHETE 01234567 Director 01/04/2018 6 yrs Approved
RITA KISHORE MASURKAR 01234567 Director 01/04/2018 6 yrs Approved
VINAY GURUDAS MASURKAR 01234567 Director 01/04/2018 6 yrs Approved
NIKHIL KISHORE MASURKAR 01234567 Director 01/04/2018 6 yrs Approved
  • 7 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
1
Capital events
2 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Eyecirque Private Limited Associate Company 74.00%

Key managerial personnel: KISHORE GURUDAS MASURKAR (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
EPFO headcount growing - hiring signal.
Operating for 44+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Compliance score is weak (38/100).
2 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 14.56 cr.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence65/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment81/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 25.55 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 6 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
25 Nov 2025
Charge satisfied
Hdfc Bank Limited
29 Sep 2025
Last AGM held
Annual general meeting
23 Sep 2025
Charge created
Others - 54.82 Lakh
07 Aug 2025
Charge satisfied
Others
04 Aug 2025
Charge created
Others - 25.00 cr
31 Mar 2025
Latest balance sheet
Filed with ROC
29 Sep 2024
Director ceased
DHARMESH PRAVIN KHARWAR
Director ceased
VIVEK MANOHAR PADGAONKAR
20 Aug 2024
Director appointed
DHARMESH PRAVIN KHARWAR (Director)
29 Jul 2024
Director appointed
VIVEK MANOHAR PADGAONKAR (Director)
27 Jun 2023
Charge satisfied
Others
Charge satisfied
The Saraswat Co-Operative Bank Limited
27 Jan 2023
Charge satisfied
Hdfc Bank Limited
30 Sep 2022
Director ceased
VIVEK RAJENDRA SHETE
18 May 2022
Securities allotted
470800 Equity Shares - 47.08 Lakh raised
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
7 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Munshi Panna Spices U15122UP2013PTC055802 Etmadpur, Uttar Pradesh, India
Bharat Motocorp Private Limited U50404TG2013PTC089833 Hyderabad, Telangana, India
Netmeds U74900MH2015PLC447671 Mumbai, Maharashtra, India
Champion Commercial Co. Ltd L51909WB1982PLC034891 Kolkata, West Bengal, India
Vaibhav International Private Limited U74120MH2011PTC217698 Malad West, Maharashtra, India
Soma Nutrition Labs Private Limited U15400PN2013PTC236271 Purandar, Maharashtra, India
Bhagwati Rice Mill Private Limited U15312UP1995PTC019042 Uttar Pradesh, Uttar Pradesh, India
Bindu Fashion Private Limited U18100HR2018PTC075623 Gurgaon, Haryana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Entod Pharm before audits and certifications: compliance score 38/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Entod Pharm: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Entod Pharm - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Entod Pharm pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Entod Pharm - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Entod Pharm an active company?

Entod Pharm has MCA status “Active” with a compliance score of 38/100 (Caution Indicated).

Is Entod Pharm financially healthy?

Entod Pharm has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Entod Pharm?

Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Entod Pharm?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 7 active director(s) are on record.

Does Entod Pharm have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 23 earlier charge(s) stand satisfied.

Is Entod Pharm up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 38/100 (Caution Indicated).

Is it risky to lend to Entod Pharm?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.